18F-FDG与68Ga-FAPI-04 PET/CT对宫颈癌影像学评估的头对头比较
本研究纳入35例宫颈癌患者,均行18F-FDG与68Ga-FAPI-04 PET/CT,以病理及至少3个月随访的CT或MRI为参考标准。两种示踪剂对原发灶检出率均为100%,原发灶与转移淋巴结SUVmax均无显著差异;68Ga-FAPI-04 PET/CT未出现18F-FDG所见的假阳性淋巴结。
要点
- 两种示踪剂对宫颈癌原发灶检出率均为100%,原发灶SUVmax无显著差异。
- 转移淋巴结检出率68Ga-FAPI-04为100%、18F-FDG为98%,SUVmax无显著差异。
- 18F-FDG PET/CT在8例患者中检出12枚假阳性淋巴结,68Ga-FAPI-04 PET/CT均未显示。
核心结论
- 68Ga-FAPI-04 PET/CT对宫颈癌原发灶及淋巴结转移的诊断具有高示踪率,并在区分转移淋巴结与反应性淋巴结方面显示良好结果。
研究设计与样本
- 纳入35例宫颈癌患者,平均年龄53±11岁(范围30-76岁),均行68Ga-FAPI-04与18F-FDG PET/CT。
- 以组织病理学及随访至少3个月的CT或MRI结果作为参考标准。
- 采用配对样本t检验比较两种示踪剂在原发灶及转移淋巴结中的SUVmax。
主要发现
- 两种示踪剂对原发肿瘤的检出率均为100%。
- 原发灶SUVmax:18F-FDG为14.5±5.7,68Ga-FAPI-04为15.1±6.2,P=0.645,无显著相关。
- 淋巴结转移检出率:68Ga-FAPI-04为100%,18F-FDG为98%。
- 转移淋巴结SUVmax:18F-FDG为7.6±4.0,68Ga-FAPI-04为7.0±3.5,P=0.572,两组间无显著差异。
- 18F-FDG PET/CT在8例患者中检出12枚假阳性淋巴结,68Ga-FAPI-04 PET/CT均未显示。
关键数值与推荐
- 原发灶SUVmax:18F-FDG 14.5±5.7 vs 68Ga-FAPI-04 15.1±6.2,P=0.645。
- 转移淋巴结SUVmax:18F-FDG 7.6±4.0 vs 68Ga-FAPI-04 7.0±3.5,P=0.572。
- 原发肿瘤检出率:18F-FDG与68Ga-FAPI-04均为100%。
- 淋巴结转移检出率:68Ga-FAPI-04为100%,18F-FDG为98%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to compare the potential value of 68 Ga-FAPI-04 and 18 F-FDG PET/CT in primary cervical cancer and lymph node metastases. METHODS: Patients with cervical cancer underwent both 68 Ga-FAPI-04 and 18 F-FDG PET/CT. Histopathology and follow-up CT or MRI results (at least 3 months of follow-up) were used as reference criteria. Paired-sample t test was used to compare the SUV max of 18 F-FDG and 68 Ga-FAPI-04 PET/CT for cervical cancer primary lesions and metastatic lymph nodes. RESULTS: A total of 35 patients with a mean age of 53 ± 11 years (range, 30-76 years) were included. The detection rate of both tracers for primary tumors was 100%. There was no significant correlation between 18 F-FDG and 68 Ga-FAPI-04 for SUV max (14.5 ± 5.7 vs 15.1 ± 6.2; P = 0.645). In addition, the detection rates of 68 Ga-FAPI-04 and 18 F-FDG for lymph node metastasis were 100% and 98%, respectively. No significant difference was found in SUV max between 18 F-FDG and 68 Ga-FAPI-04 groups (7.6 ± 4.0 vs 7.0 ± 3.5; P = 0.572). Twelve false-positive lymph nodes were detected in 8 patients with 18 F-FDG PET/CT, none of which were developed on 68 Ga-FAPI-04 PET/CT. CONCLUSION: 68 Ga-FAPI-04 PET/CT has a high tracer rate for the diagnosis of primary cervical cancer and lymph node metastases. Moreover, 68 Ga-FAPI-04 PET/CT also showed good results in distinguishing metastatic lymph nodes from reactive lymph nodes of cervical cancer.
引用
- Shu Q, He X, Chen X, et al. Head-to-Head Comparison of 18 F-FDG and 68 Ga-FAPI-04 PET/CT for Radiological Evaluation of Cervical Cancer. Clin Nucl Med. 2023. PMID: 37756446. doi:10.1097/RLU.0000000000004833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。